NCT04900688 Prospective Evaluation of the LithoVue Elite Ureteroscope
| NCT ID | NCT04900688 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre hospitalier de l'Université de Montréal (CHUM) |
| Condition | Kidney Stone |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2023-01-16 |
| Primary Completion | 2025-03-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2023-01-16 with a primary completion date of 2025-03-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Flexible ureteroscopy has become the main surgical treatment for kidney stone disease. The procedure uses many types of ureteroscopes (disposable and non-disposable). Currently we are using the LithoVue Single-Use Digital Flexible Ureteroscope. The Health Canada approved LithoVue Elite disposable flexible ureteroscope will now offer novel pressure sensory capacity. In order to evaluate the new ureteroscopy we will be conducting a prospective multi-institution study in order to determine the main features, capacity and abilities of the new scope. We will evaluate the impact of intra renal pressure on pain, quality of life and possible infectious complications.
Eligibility Criteria
Inclusion Criteria: * Patient scheduled for ureteroscopy and laser lithotripsy * Non-obstructing renal stone 2 cm total stone diameter (if multiple stones, then sum of maximum diameters) or less undergoing flexible ureteroscopy * age \> 18 years Exclusion Criteria: * age \< 18 years * pregnancy status =positive * indwelling nephrostomy tube * severe hydronephrosis that in the opinion of the investigator, will make it challenging to make the patient stone free * renal anomalies
Contact & Investigator
Naeem Dr Bhojani, MD
PRINCIPAL INVESTIGATOR
Centre hospitalier de l'Université de Montréal (CHUM)
Frequently Asked Questions
Who can join the NCT04900688 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Kidney Stone. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04900688 currently recruiting?
Yes, NCT04900688 is actively recruiting participants. Contact the research team at naeem.bhojani@gmail.com for enrollment information.
Where is the NCT04900688 trial being conducted?
This trial is being conducted at Vancouver, Canada, London, Canada, Montreal, Canada, Montreal East, Canada and 2 additional locations.
Who is sponsoring the NCT04900688 clinical trial?
NCT04900688 is sponsored by Centre hospitalier de l'Université de Montréal (CHUM). The principal investigator is Naeem Dr Bhojani, MD at Centre hospitalier de l'Université de Montréal (CHUM). The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.